Reports suggested that G6PD OE in hepatocellular carcinoma or ccRCC was mediated by Nrf2 or through synergistic overactivation of the NF-κB and pSTAT3 signaling pathways, respectively (18, 35). The gene discussed is G6PD; the disease is nonpapillary renal cell carcinoma.